Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility

被引：77

作者：

Lièvre, M

Ménard, J

Bruckert, E

Cogneau, J

Delahaye, F

Giral, P

Leitersdorf, E

Luc, G

Masana, L

Moulin, P

Passa, P

Pouchain, D

Siest, G

机构：

[1] Fac Med Laennec, Clin Pharmacol Unit, F-69376 Lyon 08, France

[2] Hop Europeen Georges Pompidou, Dept Internal Med, F-75908 Paris, France

[3] Hop La Pitie Salpetriere, Dept Endocrinol, F-75651 Paris 13, France

[4] Lyons Cardiol Hosp, F-69500 Bron, France

[5] Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel

[6] INSERM, F-59019 Lille, France

[7] Hosp Univ St Joan, Dept Internal Med, Tarragona 42201, Spain

[8] Hop St Louis, Diabetol Unit, F-75475 Paris, France

[9] INSERM, U525, Drugs Ctr, F-54000 Nancy, France

来源：

BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7286期

关键词：

D O I：

10.1136/bmj.322.7286.603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：603 / 605

页数：3

共 9 条

[1] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[2] Statins and coronary heart disease [J].

Fey, R ;

Pearson, N .

LANCET, 1996, 347 (9012) :1389-1390

[3]

Hopf G, 1997, LANCET, V350, P891, DOI 10.1016/S0140-6736(05)62079-X

[4] Early stopping of trials [J].

Langer, A .

LANCET, 1997, 350 (9081) :890-891

[5] The emerging role of statins in the prevention of coronary heart disease - Statins are effective but we need better ways of assessing risk [J].

Muldoon, MF ;

Criqui, MH .

BRITISH MEDICAL JOURNAL, 1997, 315 (7122) :1554-1555

[6] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[7] What is the optimal age for starting lipid lowering treatment? A mathematical model [J].

Ulrich, S ;

Hingorani, AD ;

Martin, J ;

Vallance, P .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7242) :1134-1140

[8]

Viberti G, 1997, LANCET, V350, P214

[9]

1997, LANCET, V350, P155

← 1 →